Bone mineral density in long-term depot medroxyprogesterone acetate acceptors

Contraception

Volumn 56, Issue 1, 1997, Pages 1-3

  Taneepanichskul, Surasak ^a   Intaraprasert, Suwachai ^a   Theppisai, Urusa ^a   Chaturachinda, Kamhaeng ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Bone density; Long term depot medroxyprogesterone acetate (DMPA) users

Indexed keywords

ESTRADIOL; MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; BONE DENSITY; CONTRACEPTION; CONTROLLED STUDY; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; NORMAL HUMAN;

ASIA; BIOLOGY; COMPARATIVE STUDIES; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE--SIDE EFFECTS; CONTRACEPTIVE AGENTS, PROGESTIN--SIDE EFFECTS; CONTRACEPTIVE AGENTS--SIDE EFFECTS; DEMOGRAPHIC FACTORS; DEVELOPING COUNTRIES; FAMILY PLANNING; LONGTERM EFFECTS; MEDROXYPROGESTERONE ACETATE--SIDE EFFECTS; PHYSIOLOGY; POPULATION; POPULATION DYNAMICS; RESEARCH METHODOLOGY; RESEARCH REPORT; SKELETAL EFFECTS; SOUTHEASTERN ASIA; STUDIES; THAILAND; TIME FACTORS;

ADULT; BONE DENSITY; COHORT STUDIES; CONFIDENCE INTERVALS; CONTRACEPTIVE AGENTS, FEMALE; DELAYED-ACTION PREPARATIONS; DENSITOMETRY, X-RAY; ESTRADIOL; FEMALE; HUMANS; INTRAUTERINE DEVICES; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; PROGESTERONE CONGENERS; PROSPECTIVE STUDIES; THAILAND; TIME FACTORS;

EID: 0030886564     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(97)00066-8     Document Type: Article

References (14)

1. Ortiz A, Hiroi F, Stanczyk FZ, Goebelsmaun U, Mishell DR, Jr. Serum medroxyprogesterone acetate (MPA) concentration and ovarian function following intramuscular injection of Depo-MPA. J Clin Endocrinol Metabol 1977;44:32-8.
2. Riggs BL, Wahner HW, Dunn WL, Mazess RB, Offord KP, Mekton LJ. Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest 1981;67:328-35.
3. Cundy T, Evans M, Roberts H, Wattie D, Ames R, Reid IR. Bone density in women receiving depot medroxyprogesterone acetate for contraception. Br Med J 1991; 303:13-6.
4. Naessen T, Olsson SE, Gudmudson J. Differential effects on bone density of progestogen-only methods for contraception in premenopausal women. Contraception 1995;52:35-9.
5. Virutamasen P, Wangsuphachart S, Reinprayoon D, Kriengsinyot R, Leepipatpaiboon S, Gua C. Trabecular bone in long-term depot-medroxyprogesterone acetate users. Asia-Oceania J Obstet Gynaecol 1994;20:269-74.
6. Johnston CC, Longcope C. Premenopausal bone loss: A risk factor for osteoporosis (Editorial). N Engl J Med 1990;323:1271-2.
7. Schlenker RA, VonSeggen WW. The distribution of cortical and trabecular bone mass along the lengths of the radius and ulna and the implications for in vivo bone mass measurements. Calcif Tissue Res 1976;20: 41-52.
8. Kaunitz AM. Long-acting injectable contraception with depot medroxyprogesterone acetate. Am J Obstet Gynecol 1994;170:1543-9.
9. Clark K, Sowers MR. Alcohol dependence, smoking status, reproductive characteristics and bone mineral density in premenopausal women. Res Nurs Health 1996;19:399-408.
10. Leboff MS, Fuleihan GE, Angell JE, Chung S, Curtis K. Dual-energy X-ray absorptiometry of the forearm: reproducibility and correlation with single-photon absorptiometry. J Bone Miner Res 1992;7:841-6.
11. Nieves JW, Cosman F, Mars C, Lindsay R. Comparative assessment of bone mineral density of the forearm using single photon and dual X-ray absorptiometry. Calcif Tissue Int 1992;51:352-5.
12. Lobo RA, McCormick W, Singer F, Roy S. Depo-medroxyprogesterone acetate compared with conjugate estrogen for the treatment of postmenopausal women. Obstet Gynecol 1984;63:1-5.
13. Abdalla HI, Hart DM, Lindsay R, Leggate I, Hooke A. Prevention of bone mineral loss in postmenopausal women by norethisterone. Obstet Gynecol 1985;66: 789-92.
14. Prior JC. Progesterone as a bone-trophic hormone. Endocrin Rev 1990;1:386-98.